Treatment of toxoplasmosis

Details Treatment of toxoplasmosis Treatment of toxoplasmosis

1994-12-16

1998-06-30

Wilson, James O.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 24, 514 46, 514261, 514262, A61K 3170

Patent

active

057734240

ABSTRACT:
Pharmaceutical compositions comprising a pharmaceutical composition comprising a compound which is an .alpha. or .beta. anomer, a D(+) or L(-) enantiomer of the following structural formula: ##STR1## wherein, R.sub.1 is a halogen, OR.sub.6, SR.sub.6, SeR.sub.6 or CH.sub.2 R.sub.6 and R.sub.6 is alkyl, alkene, arylalkyl, or aryl; ##STR2## X is CH.sub.2, O or S; R.sub.3 is H, OH, or a halogen;

REFERENCES:
patent: 4786723 (1988-11-01), Kitahara et al.
patent: 4948783 (1990-08-01), Kawai et al.
patent: 5093318 (1992-03-01), Goodman et al.
patent: 5254539 (1993-10-01), Mitsuya et al.

Affiliated with

Also associated with

Rating

Treatment of toxoplasmosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of toxoplasmosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of toxoplasmosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1859387